Efficiency of using dual-energy X-ray absorptiometry and bioimpedance analysis in assessing the component composition of the body of patients receiving treatment with programmed hemodialysis

DOI: https://doi.org/10.29296/25877305-2019-08-08
Download full text PDF
Issue: 
8
Year: 
2019

A. Yakovenko(1), Candidate of Medical Sciences; Yu. Lavrishcheva(2) 1-Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia 2-Almazov National Medical Research Centre, Saint Petersburg

The paper compares the efficiency of dual-energy X-ray absorptiometry (DXA) and bioimpedance analysis (BIA) in assessing the component composition of the body of patients on hemodialysis (HD). Examinations were made in 67 patients, including 23 men and 44 women (mean age 54.0±14.4 years), who were treated with programmed HD. The results of determining the total body muscle mass by the findings of DXA and BIA were compared with those obtained using the Bland-Altman method. The correlation coefficient between the indicators: r = 0.994 (p < 0.0001); delta (M±σ), 0.48±0.91 kg; 95% confidence interval (CI), -0.71–0.26) kg. DXA does not have significant advantages over tetrapolar multifrequency BIA in assessing the body composition of patients on HD.
Keywords: 
nephrology
dual-energy X-ray absorptiometry
bioimpedance analysis
hemodialysis
body composition

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Sabatino A., Regolisti G., Karupaiah T. et al. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis // Clin. Nutr. – 2017; 36 (3): 663–71. DOI: 10.1016/j.clnu.2016.06.007.
  2. Basic-Jukic N., Radic J., Klaric D. et al. Croatian guidelines for screening, prevention and treatment of protein-energy wasting in chronic kidney disease patients // Lijec. Vjesn. – 2015; 137 (1–2): 1–8.
  3. Obi Y., Qader H., Kovesdy C. et al. Latest consensus and update on protein-energy wasting in chronic kidney disease // Curr. Opin. Clin. Nutr. Metab. Care. – 2015; 18 (3): 254–62. DOI: 10.1097/MCO.0000000000000171.
  4. Fouque D., Kalantar-Zadeh K., Kopple J. et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease // Kidney Int. – 2008; 73 (4): 391–8.
  5. Messina C., Maffi G., Vitale J. et al. Diagnostic imaging of osteoporosis and sarcopenia: a narrative review // Quant. Imaging. Med. Surg. – 2018; 8 (1): 86–99. DOI: 10.21037/qims.2018.01.01.
  6. Battaglia Y., Galeano D., Cojocaru E. et al. Muscle-wasting in end stage renal disease in dialysis treatment: a review // G. Ital. Nefrol. – 2016; 33 (2): gin/33.2.7.
  7. Cruz-Jentoft A., Baeyens J., Bauer J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People // Age Ageing. – 2010; 39 (4): 412–23. DOI: 10.1093/ageing/afq034.
  8. Arias-Guillén M., Perez E., Herrera P. et al. Bioimpedance Spectroscopy as a Practical Tool for the Early Detection and Prevention of Protein-Energy Wasting in Hemodialysis Patients // J. Ren. Nutr. – 2018; 28 (5): 324–33. DOI: 10.1053/j.jrn.2018.02.004.
  9. European best practice guidelines Guideline on Nutrition // Nephrol. Dial. Transplant. – 2007, 22 (Suppl 2): 45–87.
  10. Guglielmi G., Ponti F., Agostini M. et al. The role of DXA in sarcopenia // Aging. Clin. Exp. Res. – 2016; 28 (6): 1047–60. DOI: 10.1007/s40520-016-0589-3.
  11. Popovic V., Zerahn B., Heaf J. Comparison of Dual Energy X-ray Absorptiometry and Bioimpedance in Assessing Body Composition and Nutrition in Peritoneal Dialysis Patients // J. Ren. Nutr. – 2017; 27 (5): 355–63. DOI: 10.1053/j.jrn.2017.03.003.
  12. Ikizler T. Optimal nutrition in hemodialysis patients // Adv. Chronic Kidney Dis. – 2013; 20 (2): 181–9.